Mobile Logo
Home / News & Events

News & Events

MedPharm Inks Deal to Support Global Pharmaceutical Company with Commercial Site Transfer
Oct 1, 2026

MedPharm Inks Deal to Support Global Pharmaceutical Company with Commercial Site Transfer

DURHAM, N.C., October 1, 2026 – MedPharm, a global leader in topical and transdermal contract drug development and manufacturing, today announced that it has signed a new agreement with a…

Continue reading
MedPharm and Palvella Therapeutics Named CPHI Awards 2026 Finalists
MedPharm and Palvella Therapeutics Named CPHI Awards 2026 Finalists
Learn more
MedPharm Expands End-to-End Proteomic Analysis Capabilities with Olink® Certification
MedPharm Expands End-to-End Proteomic Analysis Capabilities with Olink® Certification
Learn more
Purna and MedPharm to Establish Trans-Atlantic Partnership to Serve Global Clients
Purna and MedPharm to Establish Trans-Atlantic Partnership to Serve Global Clients
Learn more
Meet MedPharm at CPHI Milan 2026
Aug 4, 2026

Meet MedPharm at CPHI Milan 2026

We’re excited to be exhibiting at CPHI Milan 2026, one of the pharmaceutical industry’s leading global events. If you’re attending, we’d love the opportunity to connect and discuss how MedPharm…

Continue reading
DCAT Week 2026 — Room #1712 at The Lotte New York Palace
DCAT Week 2026 — Room #1712 at The Lotte New York Palace
Book a meeting
Webinar: From Concept to Market — Register Below
Webinar: From Concept to Market — Register Below
Book a meeting
MedPharm will be at Drug Delivery to the Lungs 2025 – Booth #180
MedPharm will be at Drug Delivery to the Lungs 2025 – Booth #180
Book a meeting

All News

Meet MedPharm at CPHI Milan 2026
Meet MedPharm at CPHI Milan 2026
Book a meeting
Webinar: From Concept to Market — Register Below
Webinar: From Concept to Market — Register Below
Book a meeting
DCAT Week 2026 — Room #1712 at The Lotte New York Palace
DCAT Week 2026 — Room #1712 at The Lotte New York Palace
Book a meeting
MedPharm Welcomes Palvella Therapeutics’ Positive Topline Results from Its Phase 3 Study of QTORIN™ Rapamycin in Microcystic Lymphatic Malformations
MedPharm Welcomes Palvella Therapeutics’ Positive Topline Results from Its Phase 3 Study of QTORIN™ Rapamycin in Microcystic Lymphatic Malformations
Learn more
Purna and MedPharm to Establish Trans-Atlantic Partnership to Serve Global Clients
Purna and MedPharm to Establish Trans-Atlantic Partnership to Serve Global Clients
Learn more
MedPharm Announces Successful U.S. FDA Inspection of its CGMP Commercial Manufacturing Facility In Durham, North Carolina
MedPharm Announces Successful U.S. FDA Inspection of its CGMP Commercial Manufacturing Facility In Durham, North Carolina
Learn more
MedPharm’s Partner Heparin Therapeutics Publishes Landmark Study on Inhaled UFH
MedPharm’s Partner Heparin Therapeutics Publishes Landmark Study on Inhaled UFH
Learn more
MedPharm Appoints Bill Humphries as Chief Executive Officer to Lead Next Phase of Strategic Growth
MedPharm Appoints Bill Humphries as Chief Executive Officer to Lead Next Phase of Strategic Growth
Learn more
MedPharm, Ltd. and Tergus Pharma Merger Forms Topical and Transepithelial CDMO Leader
MedPharm, Ltd. and Tergus Pharma Merger Forms Topical and Transepithelial CDMO Leader
Learn more
MedPharm Announces Appointment of New U.S. Director of Analytical
MedPharm Announces Appointment of New U.S. Director of Analytical
Learn more
MedPharm collaborates with Mosanna to develop new drug to tackle Metabolic Obstructive Sleep Apnea
MedPharm collaborates with Mosanna to develop new drug to tackle Metabolic Obstructive Sleep Apnea
Learn more
MedPharm Shortlisted for Two CPHI Pharma Awards
MedPharm Shortlisted for Two CPHI Pharma Awards
Learn more
Successful MHRA Audit of MedPharm Guildford
Successful MHRA Audit of MedPharm Guildford
Learn more